These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 23483729)

  • 1. Tumor suppressor function of ezrin-radixin-moesin-binding phosphoprotein-50 through β-catenin/E-cadherin pathway in human hepatocellular cancer.
    Peng XL; Ji MY; Yang ZR; Song J; Dong WG
    World J Gastroenterol; 2013 Feb; 19(8):1306-13. PubMed ID: 23483729
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NLRC5 regulates cell proliferation, migration and invasion in hepatocellular carcinoma by targeting the Wnt/β-catenin signaling pathway.
    Peng YY; He YH; Chen C; Xu T; Li L; Ni MM; Meng XM; Huang C; Li J
    Cancer Lett; 2016 Jun; 376(1):10-21. PubMed ID: 26975630
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overexpression of the long non-coding RNA SPRY4-IT1 promotes tumor cell proliferation and invasion by activating EZH2 in hepatocellular carcinoma.
    Zhou M; Zhang XY; Yu X
    Biomed Pharmacother; 2017 Jan; 85():348-354. PubMed ID: 27899259
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aberrant nuclear localization of EBP50 promotes colorectal carcinogenesis in xenotransplanted mice by modulating TCF-1 and β-catenin interactions.
    Lin YY; Hsu YH; Huang HY; Shann YJ; Huang CY; Wei SC; Chen CL; Jou TS
    J Clin Invest; 2012 May; 122(5):1881-94. PubMed ID: 22466651
    [TBL] [Abstract][Full Text] [Related]  

  • 5. EBP50 inhibits pancreatic cancer cell growth and invasion by targeting the β-catenin/E-cadherin pathway.
    Ji M; Fan D; Yuan L; Zhang Y; Dong W; Peng X
    Exp Ther Med; 2015 Oct; 10(4):1311-1316. PubMed ID: 26622484
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Repressing of NHERF1 inhibits liver cancer progression by promoting the production of ROS.
    Sun J; Li P; Yang J
    Biochem Biophys Res Commun; 2019 Jan; 509(1):8-15. PubMed ID: 30581004
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metallothionein 1H (MT1H) functions as a tumor suppressor in hepatocellular carcinoma through regulating Wnt/β-catenin signaling pathway.
    Zheng Y; Jiang L; Hu Y; Xiao C; Xu N; Zhou J; Zhou X
    BMC Cancer; 2017 Feb; 17(1):161. PubMed ID: 28241806
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The influence of downregulation of ezrin expression by RNA interference on the growth and metastasis of hepatocellular carcinoma: experiment in vitro].
    Zhang Y; Hu MY; Chen BH; Wang ZJ; Zha XL; Liu KD
    Zhonghua Yi Xue Za Zhi; 2006 Feb; 86(8):530-5. PubMed ID: 16681881
    [TBL] [Abstract][Full Text] [Related]  

  • 9. P120ctn overexpression enhances beta-catenin-E-cadherin binding and down regulates expression of survivin and cyclin D1 in BEL-7404 hepatoma cells.
    Nong CZ; Pan LL; He WS; Zha XL; Ye HH; Huang HY
    World J Gastroenterol; 2006 Feb; 12(8):1187-91. PubMed ID: 16534869
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hugl-1 induces apoptosis in esophageal carcinoma cells both in vitro and in vivo.
    Song J; Peng XL; Ji MY; Ai MH; Zhang JX; Dong WG
    World J Gastroenterol; 2013 Jul; 19(26):4127-36. PubMed ID: 23864775
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The detection of EBP50 expression using quantum dot immunohistochemistry in pancreatic cancer tissue and down-regulated EBP50 effect on PC-2 cells.
    Ji MY; Fan DK; Lv XG; Peng XL; Lei XF; Dong WG
    J Mol Histol; 2012 Oct; 43(5):517-26. PubMed ID: 22622406
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Secalonic Acid-F, a Novel Mycotoxin, Represses the Progression of Hepatocellular Carcinoma via MARCH1 Regulation of the PI3K/AKT/β-catenin Signaling Pathway.
    Xie L; Li M; Liu D; Wang X; Wang P; Dai H; Yang W; Liu W; Hu X; Zhao M
    Molecules; 2019 Jan; 24(3):. PubMed ID: 30678274
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MiR-214 targets β-catenin pathway to suppress invasion, stem-like traits and recurrence of human hepatocellular carcinoma.
    Xia H; Ooi LL; Hui KM
    PLoS One; 2012; 7(9):e44206. PubMed ID: 22962603
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Up-regulation of human cervical cancer proto-oncogene contributes to hepatitis B virus-induced malignant transformation of hepatocyte by down-regulating E-cadherin.
    Li J; Dai X; Zhang H; Zhang W; Sun S; Gao T; Kou Z; Yu H; Guo Y; Du L; Jiang S; Zhang J; Zhou Y
    Oncotarget; 2015 Oct; 6(30):29196-208. PubMed ID: 26470691
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    Li GM; Liang CJ; Zhang DX; Zhang LJ; Wu JX; Xu YC
    Chin Med J (Engl); 2018 Oct; 131(19):2320-2331. PubMed ID: 30246718
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overexpression of cancer susceptibility candidate 2 inhibited progression of hepatocellular carcinoma cells.
    Gao X; Du H; Zhang R; Li C; Wang H; Xuan Q; Liu D
    J Cell Physiol; 2019 Jun; 234(6):9008-9018. PubMed ID: 30362539
    [TBL] [Abstract][Full Text] [Related]  

  • 17. EBP50 inhibits EGF-induced breast cancer cell proliferation by blocking EGFR phosphorylation.
    Yao W; Feng D; Bian W; Yang L; Li Y; Yang Z; Xiong Y; Zheng J; Zhai R; He J
    Amino Acids; 2012 Nov; 43(5):2027-35. PubMed ID: 22476347
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potential roles of EZH2, Bmi-1 and miR-203 in cell proliferation and invasion in hepatocellular carcinoma cell line Hep3B.
    Yang F; Lv LZ; Cai QC; Jiang Y
    World J Gastroenterol; 2015 Dec; 21(47):13268-76. PubMed ID: 26715809
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of miR-99b in mediating hepatocellular carcinoma invasion and migration.
    Liu CJ; Yang JH; Huang FZ; Yang JH; Liu CP; Mao XH; Yi WM; Shen XB; Peng C; Chen MF; Jiang B; Wu JS
    Eur Rev Med Pharmacol Sci; 2018 Apr; 22(8):2273-2281. PubMed ID: 29762829
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TRIM66 promotes malignant progression of hepatocellular carcinoma by inhibiting E-cadherin expression through the EMT pathway.
    Zhang HG; Pan YW; Feng J; Zeng CT; Zhao XQ; Liang B; Zhang WW
    Eur Rev Med Pharmacol Sci; 2019 Mar; 23(5):2003-2012. PubMed ID: 30915743
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.